Meta-analysis shows systemic heparinization reduces early patency loss in adult AVF or graft placement
This meta-analysis examined the impact of systemic heparinization compared to standard care in adults undergoing arm arteriovenous fistula or graft placement. The pooled analysis included 1265 patients from the included studies. The primary outcome of interest was early patency loss, while secondary outcomes focused on bleeding complications. Follow-up duration was not reported for the individual studies within this synthesis.
The analysis found that systemic heparinization was associated with significantly reduced odds of early patency loss. The pooled odds ratio was 0.58 with a 95% confidence interval of 0.37 to 0.92. This reduction in patency loss was statistically significant with a p-value of 0.02.
Conversely, the use of systemic heparinization was associated with an increased risk of bleeding complications. The pooled odds ratio for bleeding was 4.24 with a 95% confidence interval of 1.13 to 15.9. This increase in bleeding risk was not statistically significant with a p-value of 0.13. The authors note that the absolute numbers for these events were not reported in the source data.
Practice relevance suggests that heparin may be considered a viable preventive strategy against early thrombosis. However, its use should be balanced against individual patient bleeding risk and surgical considerations. No specific funding sources or conflicts of interest were reported for this meta-analysis.